ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.56
+0.30 (3.63%)
At close: May 1, 2026, 4:00 PM EDT
8.50
-0.06 (-0.70%)
After-hours: May 1, 2026, 7:08 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $849.98 million as of May 1, 2026. Its market cap has decreased by -41.78% in one year.
Market Cap
849.98M
Enterprise Value
773.51M
1-Year Change
-41.78%
Ranking
Category
Stock Price
$8.56
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $849.98M, an increase of 49.58%. That is a compound annual growth rate of 12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 849.98M | -26.19% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 882.87M |
| Evommune | 882.45M |
| MannKind | 876.98M |
| Alto Neuroscience | 874.22M |
| Janux Therapeutics | 872.33M |
| MeiraGTx Holdings | 870.96M |
| Theravance Biopharma | 864.57M |
| Bright Minds Biosciences | 856.77M |